Huntingtin CAG repeats in neuropathologically confirmed tauopathies : Novel insights

Sergio Pérez-Oliveira, Juan Castilla-Silgado, Cèlia Painous, Iban Aldecoa, Manuel Mendez-Gonzalez, Marta Blázquez Estrada, Daniela Corte, Cristina Tomás-Zapico, Yaroslau Compta, José Esteban Muñoz García, Albert Llado Plarrumani, Mircea Balasa, Gemma Aragonès, Pablo García-González, Maitée Rosende-Roca, Mercè Boada, Agustín Ruíz, Pau Pastor, Beatriz De la Casa-Fages, Alberto RábanoRaquel Sanchez-Valle, L. Molina-Porcel, Victoria Alvarez

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

1 Citació (Web of Science)

Resum

Previous studies have suggested a relationship between the number of CAG triplet repeats in the HTT gene and neurodegenerative diseases not related to Huntington's disease (HD). This study seeks to investigate whether the number of CAG repeats of HTT is associated with the risk of developing certain tauopathies and its influence as a modulator of the clinical and neuropathological phenotype. Additionally, it aims to evaluate the potential of polyglutamine staining as a neuropathological screening. We genotyped the HTT gene CAG repeat number and APOE-ℰ isoforms in a cohort of patients with neuropathological diagnoses of tauopathies (n=588), including 34 corticobasal degeneration (CBD), 98 progressive supranuclear palsy (PSP) and 456 Alzheimer's disease (AD). Furthermore, we genotyped a control group of 1070 patients, of whom 44 were neuropathologic controls. We identified significant differences in the number of patients with pathological HTT expansions in the CBD group (2.7%) and PSP group (3.2%) compared to control subjects (0.2%). A significant increase in the size of the HTT CAG repeats was found in the AD compared to the control group, influenced by the presence of the Apoliprotein E (APOE)-ℰ4 isoform. Post-mortem assessments uncovered tauopathy pathology with positive polyglutamine aggregates, with a slight predominance in the neostriatum for PSP and CBD cases and somewhat greater limbic involvement in the AD case. Our results indicated a link between HTT CAG repeat expansion with other non-HD pathology, suggesting they could share common neurodegenerative pathways. These findings support that genetic or histological screening for HTT repeat expansions should be considered in tauopathies.
Idioma originalAnglès
Número d’articlee13250
Nombre de pàgines15
RevistaBrain Pathology
Volum34
Número4
DOIs
Estat de la publicacióPublicada - 28 de febr. 2024

Fingerprint

Navegar pels temes de recerca de 'Huntingtin CAG repeats in neuropathologically confirmed tauopathies : Novel insights'. Junts formen un fingerprint únic.

Com citar-ho